Belgium's BR2 Reactor Advances HEU to LEU Conversion with Framatome Fuel Contract

SCK-CEN, Belgium's nuclear research centre, signed a contract with Framatome for the supply of low-enriched uranium fuel for the BR2 research reactor, formalizing the commercial backbone of one of Europe's most technically demanding reactor conversion programs.

BR2 is not a typical research reactor. It operates as a high-flux facility used simultaneously for materials testing and medical isotope production, meaning any fuel swap carries consequences well beyond the reactor hall. Converting from HEU to LEU requires tailored assemblies capable of matching BR2's specific thermal-hydraulic and neutronic performance requirements while holding safety margins, a design challenge that pushed the fuel specification work squarely into Framatome's fabrication scope.

The contract covers more than delivery logistics. Framatome's role includes fuel design and fabrication, with qualification activities running in parallel through the supply pipeline before any LEU assemblies reach the actual core. That sequencing is non-negotiable: irradiation testing and post-irradiation examination have to produce a verified performance record that satisfies both the Belgian regulator and the reactor's international customer base before a core reload can happen. Fuel qualification and licensing will continue working through the pipeline in the lead-up to those first LEU reloads.

BR2's conversion sits within a larger global campaign to eliminate civilian HEU use from research reactor fleets. High-enriched uranium, enriched above 20% U-235, has been a proliferation-sensitive pressure point in non-proliferation policy for decades. Belgium moving from pledge to contracted fuel partner is a concrete milestone in that effort, not a policy statement.

From here, the project advances through detailed fabrication milestones, regulatory licensing for the new LEU assemblies, transport and installation logistics, and irradiation qualification cycles that will validate real-world performance before full conversion is complete. The Belgian regulator, international non-proliferation partners, and reactor customers whose isotope supply depends on BR2's uptime will all be tracking how the timeline holds.

A verified LEU solution for a high-flux, isotope-producing reactor of BR2's class becomes a reference point for other facilities still working through their own HEU-to-LEU calculations. That is the broader stakes riding on Framatome delivering the goods.